Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 1,124
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

1,124 results for “healthy” Back to intelligence hub

Search results

Page 42 of 47
  1. Venlafaxine Hydrochloride

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    3 trials
  2. Verdinexor

    Karyopharm Therapeutics Inc

    Healthy

    phase 1 small molecule terminated

    1 trial
  3. Vonoprazan

    Phathom Pharmaceuticals

    Healthy Participants

    phase 1 small molecule terminated

    2 trials
  4. Vonoprazan

    Phathom Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  5. Vonoprazan ODT-1 or ODT-2 without Water

    Phathom Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  6. Vortioxetine

    Takeda

    Healthy Adult Participants

    phase 1 small molecule completed

    1 trial
  7. Vortioxetine

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial
  8. WP1122

    Moleculin Biotech

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial
  9. X4P-001

    X4 Pharmaceuticals, Inc

    Healthy

    phase 1 small molecule terminated

    1 trial
  10. XEN901

    Xenon Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  11. XPF-001

    Xenon Pharmaceuticals

    Healthy Human Volunteers

    phase 1 small molecule completed

    1 trial
  12. XPF-008

    Xenon Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  13. XPF-008

    Xenon Pharmaceuticals

    Healthy Male Volunteers

    phase 1 small molecule completed

    1 trial
  14. Xanthohumol

    NORTHWEST BIOTHERAPEUTICS INC

    Healthy

    phase 1 small molecule active

    1 trial
  15. YM178

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Chinese Volunteers

    phase 1 small molecule completed

    1 trial
  16. ZB001 for injection

    Zenas BioPharma

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  17. ZB002

    Zenas BioPharma

    Healthy Volunteers

    phase 1 small molecule active

    1 trial
  18. ZB004

    Zenas BioPharma

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  19. ZN-d5

    Zentalis Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  20. ZP8396-25077

    Zealand Pharma A/S

    Healthy / hepatic impaired volunteers only study to assess PK parameters

    phase 1 other active

    1 trial
  21. Zaleplon 10 mg Capsules

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials
  22. Zasocitinib

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  23. Zithromax®

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial
  24. Zolmitriptan intranasal.

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.